AGIOS PHARMACEUTICALS, INC.
SEC Filing List
AGIO CIK: 0001439222
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Gheuens Sarah | Agios Pharmaceuticals, Inc. | 08/06/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/04/2026 | ||
| SCHEDULE 13G/A | BARNES & THORNBURG LLP /fa | 08/03/2026 | |||
| 8-K | Current report filing | Agios Pharmaceuticals, Inc. | 07/30/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Agios Pharmaceuticals, Inc. | 07/30/2026 | ||
| 4 | Statement of changes in beneficial owner... | Backstrom Jay T. | Agios Pharmaceuticals, Inc. | 07/10/2026 | |
| 4 | Statement of changes in beneficial owner... | Gheuens Sarah | Agios Pharmaceuticals, Inc. | 07/02/2026 | |
| SCHEDULE 13G | Toppan Merrill/FA | 07/02/2026 | |||
| 144 | Filing for proposed sale of securities u... | 07/01/2026 | |||
| 4 | Statement of changes in beneficial owner... | Viswanadhan Krishnan | Agios Pharmaceuticals, Inc. | 06/23/2026 | |
| No record found. | |||||
| Load More | |||||
